L. Browne

L.
Daniel Browne was the founder of Revance Therapeutics, Inc., founded in 1999, where the titles held included President, Chief Executive Officer & Director from 2014 to 2019.
Mr. Browne was the founder of Avava, Inc., founded in 2020, serving as Director from 2020 to 2022.
Current jobs include Chairman & Chief Executive Officer at Rythera Therapeutics, Inc. since 2020, Director at Galderma Holding SA, and Independent Director at Galderma Group AG since 2022.
Former jobs include President & Chief Executive Officer at Neomend, Inc. from 2001 to 2003, President & Chief Executive Officer at Prograft Medical, Inc. from 1997 to 2000, and Business Leader at W.
L.
Gore & Associates, Inc. Education includes undergraduate studies at the University of Hawai'i at Hilo and an MBA from Pepperdine Graziadio Business School.